Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

Rice University scientists used advanced CRISPR techniques to study PEX11, a protein coded by five genes in Arabidopsis plants, revealing its role in controlling peroxisome growth during the ...

The skin over a fresh wound might not look like much. In some animals, though, that thin covering becomes command central for ...

A new genomic study reveals that butterflies and moths, despite diverging over 100 million years ago, use the same two genes—ivory and optix—to produce bright warning colors. The research shows that ...

Animal-to-human organ transplants promise a future where survival no longer depends on another person’s death.

Ming, Professor of the Department of Chemical and Biological Engineering (CBE) at The Hong Kong University of Science and ...

Bacteria fend off invading viruses with molecular scissors that slice up viral DNA—a system called CRISPR that's become ...

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

Almost as soon as researchers started exploring the capabilities of the CRISPR/Cas9 system, they recognized its potential use in targeted gene editing. But the intervening decades have seen slow ...